» Articles » PMID: 37641598

Neighborhood-based Inference and Restricted Boltzmann Machine for Small Molecule-miRNA Associations Prediction

Overview
Journal PeerJ
Date 2023 Aug 29
PMID 37641598
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A growing number of experiments have shown that microRNAs (miRNAs) can be used as target of small molecules (SMs) to regulate gene expression for treating diseases. Therefore, identifying SM-related miRNAs is helpful for the treatment of diseases in the domain of medical investigation.

Methods: This article presents a new computational model, called NIRBMSMMA (neighborhood-based inference (NI) and restricted Boltzmann machine (RBM)), which we developed to identify potential small molecule-miRNA associations (NIRBMSMMA). First, grounded on known SM-miRNAs associations, SM similarity and miRNA similarity, NI was used to predict score of an unknown SM-miRNA pair by reckoning the sum of known associations between neighbors of the SM (miRNA) and the miRNA (SM). Second, utilizing a two-layered generative stochastic artificial neural network, RBM was used to predict SM-miRNA association by learning potential probability distribution from known SM-miRNA associations. At last, an ensemble learning model was conducted to combine NI and RBM for identifying potential SM-miRNA associations.

Results: Furthermore, we conducted global leave one out cross validation (LOOCV), miRNA-fixed LOOCV, SM-fixed LOOCV and five-fold cross validation to assess performance of NIRBMSMMA based on three datasets. Results showed that NIRBMSMMA obtained areas under the curve (AUC) of 0.9912, 0.9875, 0.8376 and 0.9898 ± 0.0009 under global LOOCV, miRNA-fixed LOOCV, SM-fixed LOOCV and five-fold cross validation based on dataset 1, respectively. For dataset 2, the AUCs are 0.8645, 0.8720, 0.7066 and 0.8547 ± 0.0046 in turn. For dataset 3, the AUCs are 0.9884, 0.9802, 0.8239 and 0.9870 ± 0.0015 in turn. Also, we conducted case studies to further assess the predictive performance of NIRBMSMMA. These results illustrated the proposed model is a useful tool in predicting potential SM-miRNA associations.

References
1.
Wang Y, Zeng J . Predicting drug-target interactions using restricted Boltzmann machines. Bioinformatics. 2013; 29(13):i126-34. PMC: 3694663. DOI: 10.1093/bioinformatics/btt234. View

2.
Wang J, Meng F, Dai E, Yang F, Wang S, Chen X . Identification of associations between small molecule drugs and miRNAs based on functional similarity. Oncotarget. 2016; 7(25):38658-38669. PMC: 5122418. DOI: 10.18632/oncotarget.9577. View

3.
Li J, Lei K, Wu Z, Li W, Liu G, Liu J . Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs. Oncotarget. 2016; 7(29):45584-45596. PMC: 5216744. DOI: 10.18632/oncotarget.10052. View

4.
Meng F, Dai E, Yu X, Zhang Y, Chen X, Liu X . Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease. J R Soc Interface. 2013; 11(92):20131057. PMC: 3899875. DOI: 10.1098/rsif.2013.1057. View

5.
Yao J, Li Z, Wang X, Xu P, Zhao L, Qian J . MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20. Acta Biochim Biophys Sin (Shanghai). 2016; 48(2):202-8. DOI: 10.1093/abbs/gmv129. View